Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study

Hideki Mori, Hidekazu Suzuki, Juntaro Matsuzaki, Hitoshi Tsugawa, Seiichiro Fukuhara, Sawako Miyoshi, Kenro Hirata, Takashi Seino, Misako Matsushita, Toshihiro Nishizawa, Tatsuhiro Masaoka, Takanori Kanai

Research output: Contribution to journalArticlepeer-review

34 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study'. Together they form a unique fingerprint.

Medicine & Life Sciences